This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Graceway Pharmaceuticals, LLC
Graceway Pharmaceuticals, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a key provider of innovative healthcare solutions, focusing primarily on dermatology and other specialty areas. With a commitment to developing high-quality prescription medications, Graceway Pharmaceuticals has achieved significant milestones, including the successful launch of several unique products that address unmet medical needs. The company’s core offerings include topical treatments and therapies that stand out for their efficacy and safety profiles. Graceway's dedication to research and development has positioned it as a trusted name in the market, earning recognition for its contributions to patient care. With a strong operational presence across the US and beyond, Graceway Pharmaceuticals continues to strive for excellence in delivering effective healthcare solutions.
DitchCarbon Score
How does Graceway Pharmaceuticals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Graceway Pharmaceuticals, LLC's score of 40 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Graceway Pharmaceuticals, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Bausch Health Companies Inc., any climate commitments or emissions data would be inherited from this parent organisation. Graceway Pharmaceuticals has not publicly disclosed any specific reduction targets or initiatives related to carbon emissions. However, it is important to note that the climate commitments and performance metrics may be influenced by the broader sustainability strategies implemented by Bausch Health Companies Inc., which operates at a cascade level of 2 in relation to Graceway. As of now, Graceway Pharmaceuticals has not outlined any specific climate pledges or initiatives, nor have they reported on their participation in industry-standard frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The absence of detailed emissions data and reduction targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 46,686,000 | 00,000,000 |
| Scope 2 | 50,513,000 | 00,000,000 |
| Scope 3 | 19,260,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Graceway Pharmaceuticals, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
